Form D · Biotechnology
Thermalin Diabetes, LLC
Cleveland, OH · CIK 0001502127
Offering snapshot reported Jul 28, 2014 · SEC filing
- Reported sold
- $6.65M Offering amount: $14M
- Investors reported
- 71 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jun 26, 2013 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$3,142,094 → $6,654,859
- Reported investors28 → 71
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2014 | Amendment | $6,654,859 | $3,512,765vs Jul 10, 2013 | 71 | SEC filing |
| Sep 3, 2013 | Initial | $2,525,000 | No comparison | 33 | SEC filing |
| Jul 10, 2013 | Initial | $3,142,094 | No comparison | 28 | SEC filing |
| Mar 29, 2011 | Amendment | $2,812,759 | $320,500vs Feb 24, 2011 | 37 | SEC filing |
| Feb 24, 2011 | Amendment | $2,492,259 | $588,362vs Oct 21, 2010 | 35 | SEC filing |
| Oct 21, 2010 | Initial | $1,903,897 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-199310
Series B Preferred Shares. The minumum amount reflected in Item 11 may be waived by the Issuer.
Source: Form D, filed Jul 28, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Berenson | Director, Executive, Promoter |
| Mitchell Briskin | Executive |
| John Brooks | Director |
| Jeffrey Elton | Director |
| Bruce H. Frank | Executive |
| Joseph Jankowski | Director |
| Raymond Rackley | Director |
| Steven Tregay | Director |
| Michael Weiss | Director, Executive, Promoter |
| Gerald Wisler | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10000 Cedar Avenue
Cleveland, OH, 44106
Cleveland, OH, 44106